Study on cardiovascular health in naval personnel

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to track the incidence and prevalence of cardiovascular diseases among newly appointed cadets in Naval Academies from 2014 to 2025. Participants will undergo physical examinations and complete questionnaires regarding their dietary habits, physical activity, and mental health, including anxiety and depression levels. Blood tests will also be conducted to gather comprehensive health data. Follow-up interviews will occur every three years, with a total follow-up period extending ten years after the last class enrollment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

\-

Exclusion Criteria:

* Non signed consent form

Where it's running

• Athens Naval Hospital
  Athens, Athens, Greece Recruiting

Study contacts

• Principal investigator: Aikaterini Roumpi, MD MSc — Athens Naval Hospital
• Study coordinator: Antonios Mastrokostopoulos, MD MSc
• Email: amastrokostopoulos@yahoo.com
• Phone: 00302107261000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Examining health determinants and their impact on chronic diseases

  This study looks at how personal choices and community factors affect heart health and other long-term illnesses to see what really impacts people's health.

  Recruiting at 34 sites Population Health Research Institute · Rosario, Santa Fe Province and 33 other locations · NCT03225586

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.